openPR Logo
Press release

Global Empagliflozin, Dapagliflozin And Canagliflozin Market Outlook 2025-2034: Trends, Innovations, And Future Outlook

05-27-2025 06:16 AM CET | Health & Medicine

Press release from: The Business Research Company

Empagliflozin, Dapagliflozin And Canagliflozin Market

Empagliflozin, Dapagliflozin And Canagliflozin Market

The Empagliflozin, Dapagliflozin And Canagliflozin Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Empagliflozin, Dapagliflozin And Canagliflozin Market Size and Projected Growth Rate?
The empagliflozin, dapagliflozin and canagliflozin market size has grown steadily in recent years. It will grow from $9.64 billion in 2024 to $9.94 billion in 2025 at a compound annual growth rate (CAGR) of 3.1%. The growth in the historic period can be attributed to the increase in the prevalence of type 2 diabetes globally, increased awareness about the benefits of SGLT2 inhibitors, growth in the elderly population, growth in the prevalence of obesity, and increase in focus on personalized medicine.

The empagliflozin, dapagliflozin, and canagliflozin market is expected to see steady growth, projected to reach $11.06 billion by 2029, at a compound annual growth rate (CAGR) of 2.7%. Growth drivers include the increasing demand for oral diabetes medications, higher investments in diabetes research, rising healthcare expenditures, greater awareness and diagnosis of pre-diabetes, and the shift toward combination therapies. Key trends include advancements in drug development, combination therapies, telehealth, health data analytics, and data security.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18350

What Are the Major Segments in the Empagliflozin, Dapagliflozin And Canagliflozin Market?
The empagliflozin, dapagliflozin and canagliflozin market covered in this report is segmented -

1) By Type: Empagliflozin, Dapagliflozin, Canagliflozin
2) By Application: Application I, Application II, Application III, Application IV
3) By Channel: Hospital, Pharmacy

Subsegments:
1) Empagliflozin: 10 Mg, 25 Mg, 50 Mg
2) Dapagliflozin: 5 Mg, 10 Mg
3) Canagliflozin: 100 Mg, 300 Mg

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18350&type=smp

What Are The Driving Empagliflozin, Dapagliflozin And Canagliflozin Market Evolution?
The increasing prevalence of diabetes is expected to drive the growth of the empagliflozin, dapagliflozin, and canagliflozin market. These medications are used in the treatment of diabetes by inhibiting SGLT2 in the kidneys, thereby helping to lower blood sugar levels. As diabetes rates rise due to factors such as unhealthy diets, sedentary lifestyles, and aging populations, the demand for these treatments is expected to continue growing. A report from the UK's National Health Service highlighted an alarming increase in diabetes cases, further underscoring the growing need for SGLT2 inhibitors.

Which Firms Dominate The Empagliflozin, Dapagliflozin And Canagliflozin Market Segments?
Major companies operating in the empagliflozin, dapagliflozin and canagliflozin market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., MSN Laboratories Private Limited, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Cadila Healthcare Limited, Apotex Inc., Lupin Limited, Biocon Limited, Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd.

What Empagliflozin, Dapagliflozin And Canagliflozin Market Trends Are Gaining Traction Across Different Segments?
Leading companies in the sector of empagliflozin, dapagliflozin, and canagliflozin markets are concentrating on development of revolutionary products like pediatric type-2 diabetes treatment, allowing them to cater to a wider range of patient demographics and broaden their scope in the diabetes care market. The approach to treating pediatric Type-2 diabetes involves controlling blood sugar levels through changes in lifestyle, the use of medications and occasionally, insulin therapy specially designed for children and young adolescents. For example, AstraZeneca, a prominent pharmaceutical company from the UK, announced in June 2024, that Farxiga (dapagliflozin) has been approved by the US Food and Drug Administration (FDA) for enhancing glycemic control in pediatric patients who are 10 years old and above, diagnosed with type 2 diabetes. This approval came on the back of positive results attained from the T2NOW Phase III clinical trial, which is one of the most comprehensive pediatric type-2 diabetes trials so far, showcasing that Farxiga considerably lowered HbA1c levels when compared to a placebo. The safety profile of Farxiga in pediatrics mirrors that noted in adults with type-2 diabetes. This approval marks an essential landmark, considering that oral treatment options for Pediatric type-2 diabetes were limited till now. Moreover, it emphasizes AstraZeneca's dedication towards developing leading-edge treatments in the sectors of cardiovascular, renal, and metabolic diseases.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/empagliflozin-dapagliflozin-and-canagliflozin-global-market-report

Which Is The Largest Region In The Empagliflozin, Dapagliflozin And Canagliflozin Market?
North America was the largest region in the empagliflozin, dapagliflozin and canagliflozin market in 2024. The regions covered in the empagliflozin, dapagliflozin and canagliflozin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Empagliflozin, Dapagliflozin And Canagliflozin Market?
2. What is the CAGR expected in the Empagliflozin, Dapagliflozin And Canagliflozin Market?
3. What Are the Key Innovations Transforming the Empagliflozin, Dapagliflozin And Canagliflozin Industry?
4. Which Region Is Leading the Empagliflozin, Dapagliflozin And Canagliflozin Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Empagliflozin, Dapagliflozin And Canagliflozin Market Outlook 2025-2034: Trends, Innovations, And Future Outlook here

News-ID: 4037020 • Views: …

More Releases from The Business Research Company

Emerging Trends to Reshape the Xenotransplantation Market: Xvivo's Innovative Preservation Technology Paves The Way For Xenotransplantation Advancements as a Key Influencer
Emerging Trends to Reshape the Xenotransplantation Market: Xvivo's Innovative Pr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Xenotransplantation Market Size By 2025? The market size of xenotransplantation has seen robust expansion in the past few years. The market value is projected to increase from $14.68 billion in 2024 to $15.82 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 7.8%.…
Wood Based Panel Market Landscape to 2034: Key Forces Shaping the Next Decade of Growth
Wood Based Panel Market Landscape to 2034: Key Forces Shaping the Next Decade of …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Wood Based Panel Market Through 2025? In recent times, the market size of wood-based panels has seen considerable growth. The market which was valued at $176.85 billion in 2024 is projected to rise to $190.52 billion in 2025, showing a compound annual…
Soaring Demand Set to Propel Wireless Speakers Market to $111.25 Billion by 2029
Soaring Demand Set to Propel Wireless Speakers Market to $111.25 Billion by 2029
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Wireless Speakers Market Size Growth Forecast: What to Expect by 2025? In recent times, the wireless speakers market has experienced substantial expansion. The market size is expected to increase from $37.14 billion in 2024 to $45.71 billion in 2025, growing at a compound annual growth rate (CAGR) of 23.1%.…
Wind Turbine Casting Market Landscape 2025: Forecast Data and Growth Strategy Insights
Wind Turbine Casting Market Landscape 2025: Forecast Data and Growth Strategy In …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Wind Turbine Casting Industry Market Size Be by 2025? The market size for wind turbine castings has seen solid growth in the past few years. Its value is projected to increase from $2.31 billion in 2024 to $2.46 billion in 2025, with a compound annual growth…

All 5 Releases


More Releases for Empagliflozin

Empagliflozin Impurity Standards: Ensuring Uncompromised Drug Quality with Preci …
Empagliflozin, a widely prescribed medication for managing Type 2 diabetes, has revolutionized the approach to treatment by enabling better glycemic control and reducing cardiovascular risks. As its demand grows, so does the need for impeccable quality standards to ensure its efficacy and safety for patients worldwide. Integral to achieving this is the availability of well-characterized impurity standards, which form the cornerstone for rigorous quality testing. To meet these precise requirements, Empagliflozin…
Lizhuo Pharmaceutical Technology: Empagliflozin Intermediate 3 CAS NO. 1279691-3 …
Product Name:Empagliflozin Intermediate 3 Image: https://www.abnewswire.com/upload/2025/02/244d490e8e67be1fc6fd489f30405e07.jpg CAS NO.:1279691-36-9 Synonyms: Empagliflozin N-1; (2S,3R,4S,5S,6R)-2-(3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)-4-chlorophenyl)-tetrahydro-6-(hydroxyMethyl)-2-Methoxy-2H-pyran-3,4,5-triol; Methyl 1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]Methyl]phenyl]-alpha-D-glucopyranoside; Related Categories:Empagliflozin intermediates; pharmaceutical raw materials; pharmaceutical intermediates; organic intermediates. Appearance: White to Off-White solid Purity: 98% Application: Empagliflozin intermediates;pharmaceutical intermediate Supply Ability Empagliflozin Intermediate3 CAS NO.1279691-36-9 is our regularly production product, whether you need small sample or a large cargo of more than tonnage, our company can supply it formally If you are interested in Empagliflozin Intermediate3 CAS NO.1279691-36-9, feel freely contact us please, and we will provide…
Empagliflozin, Dapagliflozin And Canagliflozin Market Report By Size, Share And …
The Business Research Company recently released a comprehensive report on the Global Empagliflozin, Dapagliflozin And Canagliflozin Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free…
Empagliflozin, Dapagliflozin And Canagliflozin Market Size, Share Analysis And T …
The new report published by The Business Research Company, titled Empagliflozin, Dapagliflozin And Canagliflozin Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the empagliflozin, dapagliflozin and canagliflozin market size has grown steadily in recent years. It will grow from…
Empagliflozin, Dapagliflozin and Canagliflozin Market Research Report 2023: …
Empagliflozin, Dapagliflozin and Canagliflozin are three main types of SGLT-2 inhibitors. Global Empagliflozin, Dapagliflozin and Canagliflozin Market: Driven factors and Restrictions factors The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes an evaluation of trends, restraints, and drivers that influence the market positively or negatively. The report also outlines the potential impact of different segments and applications on the market in the…
Empagliflozin Tablets Market Opportunities and Growth Challenges Report 2022-203 …
Global Empagliflozin Tablets Market 2022-2028 - Global Industry Size, Supply Analysis, Price Analysis, Consumption and Production, Supplier and Cost Structure Analysis Empagliflozin Tablets Market Overview The recent market intelligence study by the research analysts at Market Business Insights (MBI) takes a deep dive into inner operations of the global Empagliflozin Tablets Market. It thoroughly examines the market landscape to give the readers an accurate insight into the current, as well as the…